hyaluronoglucosaminidase has been researched along with Astrocytoma, Grade IV in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Acar, S; Alemany, R; Barçın, E; Ghouse, SM; Kawamura, Y; Kiyokawa, J; Martínez-Quintanilla, J; Martuza, RL; Rabkin, SD; Shah, K; Wakimoto, H | 1 |
| de Vega, S; Hara, H; Inoue, S; Nakamura, S; Okada, Y; Shimazawa, M; Tsuji, S; Yamada, T | 1 |
| Alemany, R; He, D; Martinez-Quintanilla, J; Shah, K; Wakimoto, H | 1 |
| Diaconu, E; Guo, K; Haqqi, T; Liu, D; Markowitz, S; Mori, H; Pearlman, E; Sy, MS; Willson, J | 1 |
| Haselsberger, K; Pendl, G; Radner, H | 2 |
| Baumgartner, G; Gomar-Höss, C; Sakr, L; Ulsperger, E; Wogritsch, C | 1 |
| Enegd, B; Kaye, AH; King, JA; Novak, U; Paradiso, L; Stylli, S | 1 |
| Baumgarmer, G; Grunert, P; Horaczek, A; Kitz, K; Wunsch, M | 1 |
1 trial(s) available for hyaluronoglucosaminidase and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Extracellular Matrix; Female; Glioblastoma; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Pilot Projects; Survival Rate | 1998 |
8 other study(ies) available for hyaluronoglucosaminidase and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Topics: Adenoviridae; Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Extracellular Matrix; Female; Glioblastoma; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immune Checkpoint Inhibitors; Immunotherapy; Mice; Oncolytic Virotherapy; Oncolytic Viruses; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Gene Knockdown Techniques; Glioblastoma; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Prognosis; RNA, Small Interfering; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.
Topics: Adenoviridae; Animals; Biomimetic Materials; Brain Neoplasms; Cell Line, Tumor; Extracellular Matrix; Gene Expression; Glioblastoma; HEK293 Cells; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intralesional; Mesenchymal Stem Cells; Mice; Mice, Nude; Oncolytic Virotherapy; Survival Analysis; Viral Proteins; Virus Replication; Xenograft Model Antitumor Assays | 2015 |
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.
Topics: Animals; Base Sequence; Cell Division; Chamomile; Colonic Neoplasms; Cornea; DNA Primers; Enzyme Inhibitors; Female; Flavonoids; Glioblastoma; Glioma; Humans; Hyaluronoglucosaminidase; Melanoma; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oils, Volatile; Plants, Medicinal; Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcription, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma.
Topics: Adult; Aged; Biological Availability; Blood-Brain Barrier; Borohydrides; Boron Neutron Capture Therapy; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glioblastoma; Humans; Hyaluronoglucosaminidase; Infusions, Intravenous; Male; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Sulfhydryl Compounds | 1996 |
Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase.
Topics: Boron; Chemotherapy, Adjuvant; Clinical Trials as Topic; Glioblastoma; Humans; Hyaluronoglucosaminidase; Neutron Capture Therapy; Tissue Distribution | 1998 |
Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity.
Topics: Acetylglucosaminidase; Animals; Antigens, Neoplasm; Astrocytoma; beta-N-Acetylhexosaminidases; Brain Neoplasms; Carcinogenicity Tests; Cell Division; Gene Expression; Glioblastoma; Glioma; Glucuronosyltransferase; Histone Acetyltransferases; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Neoplasm Proteins; Neoplasm Transplantation; Protein Isoforms; Skin Neoplasms; Transfection; Tumor Cells, Cultured | 2002 |
[Hyaluronidase as an adjuvant to cystostatic chemotherapy in glioblastoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Hyaluronoglucosaminidase; Male; Middle Aged | 1987 |